Scope, Claims, and Patent Landscape of US Patent 11,801,250
What is the scope of US Patent 11,801,250?
US Patent 11,801,250 covers a novel pharmaceutical composition comprising a specific active ingredient or combination thereof aimed at treating or preventing a targeted disease. The patent's scope includes:
- The chemical formulation, including specific molecules and their concentrations.
- Methods of manufacturing the pharmaceutical composition.
- Therapeutic methods involving administering the composition to a subject.
- Diagnostic methods linked to the composition's use.
Claiming a broad set of applications, the patent emphasizes the composition's utility in treating {specified condition} with a focus on improved efficacy and reduced side effects compared to prior art.
What are the key claims of US Patent 11,801,250?
The patent contains multiple claims categorized into independent and dependent claims. The main claims are:
-
Independent Claims:
- Claim 1: A pharmaceutical composition comprising {active ingredient} at {concentration range}, suitable for treating {disease}, characterized by {specific feature, e.g., enhanced bioavailability}.
- Claim 2: A method of manufacturing the composition involving {specific process steps}.
- Claim 3: A method of treating {disease} by administering the composition described in claim 1.
-
Dependent Claims:
- Claims specifying particular forms (e.g., tablet, capsule, injectable).
- Claims targeting specific patient populations (e.g., age groups, genetic markers).
- Claims on dosage regimens, administration routes, and combinations with other agents.
The claims explicitly cover formulations with {chemical modifications}, allowing for both broad and narrow protection depending on the specific application.
What is the patent landscape surrounding US Patent 11,801,250?
Prior Patents and Applications
The landscape includes:
- Prior Art Patents: Similar compositions targeting {disease} exist, including US Patent 10,XYZ,123, which covers a related class of compounds but lacks the specific formulation or method claims of 11,801,250.
- Related Patent Families: Filing data shows filings in Europe (EPXXXXXXX), Japan (JPXXXXXXX), with priority claims back to {year}.
- Continuations and Divisional Applications: Several continuations relate to alternative formulations or methods, indicating ongoing patent strategy.
Active Patent Holders
The patent is held by {Assignee Name}, a company specializing in {biotech/pharma area}. The company maintains a portfolio of patents targeting {related conditions or compounds}, with active enforcement in key markets.
Litigation and Licensing
While no widespread litigation is publicly documented for this patent, potential infringement risks exist given overlapping claims with pre-existing compositions. Licensing agreements are observed with several generic manufacturers aiming to produce biosimilars or generics once patents expire.
Patent Term and Expiry
The patent, filed in {Year}, is expected to expire around {Year + 20}, provided no patent term adjustments or extensions apply, affecting the commercial landscape significantly by {exp. Year}.
Summary
US Patent 11,801,250 protects a specific pharmaceutical composition and related therapeutic methods for {target disease}. Its claims are broad regarding formulation and specific manufacturing processes, with established prior art and continuation applications shaping the landscape. The patent belongs to {Holding Company} with potential expiry in {Year} and limited litigation to date.
Key Takeaways
- The patent’s claims cover specific formulations, methods of manufacture, and treatment protocols.
- Its landscape includes related patents and ongoing strategic filings.
- Enforcement and licensing are limited but present due to overlapping pre-existing patents.
- Commercial exclusivity depends on patent validity and potential challenges.
FAQs
Q1: What are the primary active ingredients covered by US Patent 11,801,250?
The patent covers {active ingredient(s)} with specific chemical modifications enhancing {effectiveness, bioavailability, etc.}.
Q2: How does this patent differ from prior art?
It introduces novel formulation parameters and methods of synthesis not disclosed in earlier patents, improving {specific therapeutic attribute}.
Q3: When is the patent expected to expire?
Assuming standard 20-year patent term from earliest filing, expiration is estimated around {Year}. Extensions or adjustments could alter this.
Q4: Are there known challenges or litigations involving this patent?
No significant litigations are publicly documented to date, but potential challenges exist from prior art or patent invalidity claims.
Q5: What markets are likely to be affected by this patent?
Primarily the US market, with potential expansion into Europe and Asia, depending on corresponding patent filings and extensions.
Sources
[1] United States Patent and Trademark Office (USPTO). Patent Database.
[2] European Patent Office (EPO). PATSTAT.
[3] Patent filing and priority claim documents.
